Medications

Reclassification recommendations for drug in 'magic mushrooms'

In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule ...

Psychology & Psychiatry

Study suggests psychedelic drugs could reduce criminal behavior

Classic psychedelics such as psilocybin (often called magic mushrooms), LSD and mescaline (found in peyote) are associated with a decreased likelihood of antisocial criminal behavior, according to new research from investigators ...

Psychology & Psychiatry

Psilocybin inhibits the processing of negative emotions in the brain

Emotions like fear, anger, sadness, and joy enable people to adjust to their environment and react flexibly to stress and strain and are vital for cognitive processes, physiological reactions, and social behaviour. The processing ...

Neuroscience

Low doses of psychedelic drug erases conditioned fear in mice

(Medical Xpress)—Low doses of a psychedelic drug erased the conditioned fear response in mice, suggesting that the agent may be a treatment for post-traumatic stress disorder and related conditions, a new study by University ...

page 1 from 2